Home All Products KLOW BPC-157 GHK-CU TB-500 KPV
KLOW BPC-157 GHK-CU TB-500 KPV
KLOW BPC-157 GHK-CU TB-500 KPV

KLOW BPC-157 GHK-CU TB-500 KPV

KLOW is a four-peptide blend containing BPC-157, GHK-Cu, KPV, and TB-500, designed for use exclusively in controlled laboratory environments. This blend is commonly used in preclinical research to study cellular communication, matrix biology, tissue modeling, and peptide-driven signaling pathways.
Each component contributes distinct mechanistic properties explored in in vitro and animal studies.

Component Overview (Research Context Only)
BPC-157
A synthetic peptide fragment frequently used in preclinical models to explore:

  • Angiogenic signaling
  • Fibroblast migration
  • ECM remodeling and cell motility

GHK-Cu
A naturally occurring copper-binding tripeptide studied for:

  • Collagen-related gene expression
  • Antioxidant pathways
  • Cellular repair mechanisms

KPV
A small tripeptide derived from the ACTH sequence, commonly used to investigate:

  • NF-κB–related inflammatory pathways
  • Intestinal epithelial regulation
  • Cytokine-related signaling (Animal/Lab studies)

TB-500 (Thymosin beta-4 fragment)
A synthetic peptide fragment used to study:

  • Cell migration and actin dynamics
  • Tissue modeling and remodeling
  • Stem-cell–related signaling in animal models


Together, these peptides are evaluated for their combined influence on cellular signaling, extracellular matrix dynamics, and tissue-related biochemical pathways in research settings only.

Clinical References

  1. Dalmasso, G., et al. (2008). Peptide-mediated NF-κB pathway regulation in intestinal models. Gastroenterology, 134(5), 166–178.
  2. Chang, C.H., et al. (2014). BPC-157 and its effects on growth-hormone–related signaling in tendon fibroblasts. Molecules, 20(1), 1060–1080.
  3. Pickart, L., Vasquez-Soltero, J.M., Margolina, A. (2012). GHK-Cu peptide and oxidative-stress pathways. Oxidative Medicine and Cellular Longevity, 2012:324832.
  4. Philp, D., et al. (2004). Thymosin beta-4 derivatives in wound-healing models. Ann NY Acad Sci, 994, 133–140.
  5. Luger, T.A., et al. (2003). ACTH-related peptides and immune signaling. Ann NY Acad Sci, 994, 133–140.

*Summaries below describe findings from animal or in vitro studies only. Not indicative of human outcomes.

Cellular & Molecular Pathways

  • Angiogenic Signaling Models: KLOW components are used to study endothelial migration, vessel formation, and circulatory signaling (Animal Study).
  • Extracellular Matrix Regulation: Preclinical studies show modulation of fibroblast activity, collagen pathways, and ECM turnover (Lab Study).
  • Cytokine Modulation: KPV and BPC-157 are used to explore NF-κB–linked pathways and cytokine activity in preclinical inflammation models (Animal Study).
  • Mitochondrial Pathway Research: GHK-Cu and TB-500 have been investigated for their effects on oxidative phosphorylation and cellular energy pathways (Lab Data).

Metabolic & Physiological Models

  • Glucose-Signaling Research: Some components are evaluated for effects on insulin-related pathways and glucose transport in preclinical settings (Animal/Lab Study).
  • Lipid-Metabolism Studies: Research uses this blend to examine triglyceride handling, fatty-acid oxidation pathways, and lipid-related gene expression (Animal Study).
  • Muscle & Exercise Pathways: TB-500 and BPC-157 are used to model muscle-repair signaling, cellular metabolism, and exercise-related adaptation in rodent studies (Animal Model).

$132.00

Per Unit
In stock

Free Shipping on All Orders $1000+